Beckerman Institutional LLC Makes New Investment in iShares Biotechnology ETF (NASDAQ:IBB)

Beckerman Institutional LLC purchased a new stake in iShares Biotechnology ETF (NASDAQ:IBB) during the third quarter, according to its most recent 13F filing with the SEC. The firm purchased 2,721 shares of the financial services provider’s stock, valued at approximately $396,000.

A number of other institutional investors and hedge funds have also recently modified their holdings of IBB. Graypoint LLC boosted its position in shares of iShares Biotechnology ETF by 8.4% in the 3rd quarter. Graypoint LLC now owns 1,613 shares of the financial services provider’s stock worth $235,000 after purchasing an additional 125 shares in the last quarter. Blake Schutter Theil Wealth Advisors LLC acquired a new stake in iShares Biotechnology ETF in the third quarter worth about $260,000. D.B. Root & Company LLC acquired a new stake in iShares Biotechnology ETF in the third quarter worth about $333,000. Concurrent Investment Advisors LLC grew its stake in shares of iShares Biotechnology ETF by 3.4% during the third quarter. Concurrent Investment Advisors LLC now owns 3,712 shares of the financial services provider’s stock worth $541,000 after acquiring an additional 123 shares during the last quarter. Finally, Milestone Investment Advisors LLC increased its holdings in shares of iShares Biotechnology ETF by 36.1% during the third quarter. Milestone Investment Advisors LLC now owns 6,730 shares of the financial services provider’s stock valued at $980,000 after acquiring an additional 1,786 shares in the last quarter. Hedge funds and other institutional investors own 62.45% of the company’s stock.

iShares Biotechnology ETF Stock Up 0.6 %

Shares of iShares Biotechnology ETF stock opened at $148.85 on Friday. iShares Biotechnology ETF has a 52 week low of $113.56 and a 52 week high of $150.57. The company has a 50 day moving average price of $144.84 and a 200 day moving average price of $141.09.

iShares Biotechnology ETF Announces Dividend

The company also recently announced a dividend, which was paid on Monday, September 30th. Investors of record on Wednesday, September 25th were paid a $0.2005 dividend. The ex-dividend date was Wednesday, September 25th.

About iShares Biotechnology ETF

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.